Therefore, the mutual positive regulatory relationship between USP9X and TGF-β signaling occurs through various physiological and pathological processes, which makes USP9X an appropriate target of TGF-β signaling in HGSOC or other cancers. The gene discussed is USP9X; the disease is cancer.